Cargando…
Second-Generation JK-206 Targets the Oncogenic Signal Mediator RHOA in Gastric Cancer
SIMPLE SUMMARY: Ras homologous A (RHOA), a signal mediator and a GTPase, is associated with the progression of gastric cancer (GC). We present novel RHOA inhibitors designed for greater anti-GC potency by means of lead optimization. The RHOA → BIRC5 signaling circuit was found to be a new therapeuti...
Autores principales: | Beak, Myeonghun, Park, Sungjin, Kim, Jin-Hee, Eom, Hyo Jin, Lee, Ho-Yeon, Kim, Yon Hui, Lee, Jinhyuk, Nam, Seungyoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997135/ https://www.ncbi.nlm.nih.gov/pubmed/35406376 http://dx.doi.org/10.3390/cancers14071604 |
Ejemplares similares
-
Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 α inhibitor BI6015
por: Kim, Jin-Hee, et al.
Publicado: (2019) -
Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer
por: Chang, Hae Ryung, et al.
Publicado: (2016) -
Clinical Relevance and Molecular Phenotypes in Gastric Cancer, of TP53 Mutations and Gene Expressions, in Combination With Other Gene Mutations
por: Park, Sungjin, et al.
Publicado: (2016) -
RHOA in Gastric Cancer: Functional Roles and Therapeutic Potential
por: Nam, Seungyoon, et al.
Publicado: (2019) -
RHOA protein expression correlates with clinical features in gastric cancer: a systematic review and meta-analysis
por: Nam, Seungyoon, et al.
Publicado: (2022)